Kathryn E Weaver

Kathryn E Weaver

Wake Forest University

H-index: 40

North America-United States

About Kathryn E Weaver

Kathryn E Weaver, With an exceptional h-index of 40 and a recent h-index of 31 (since 2020), a distinguished researcher at Wake Forest University, specializes in the field of Cancer Survivorship, Cancer Care Delivery.

His recent articles reflect a diverse array of research interests and contributions to the field:

Biomarkers associated with atherosclerosis-related cardiovascular dysfunction in cancer survivors treated with anthracyclines

Abstract PO1-12-11: How do chemotherapy and age affect physical performance in breast cancer patients over 12 months of treatment? Results from the UPBEAT Study (UPBEAT WF-97415)

Availability of cancer survivorship support services across the National Cancer Institute Community Oncology Research Program network

CHANGES IN SKELETAL MUSCLE QUALITY DURING RECEIPT OF ANTHRACYCLINE-BASED CHEMOTHERAPY

Processes for identifying caregivers and screening for caregiver and patient distress in community oncology: results from WF-1803CD

ASSOCIATION OF INTERMUSCULAR FAT AND PHYSICAL ACTIVITY LEVELS ON EXERCISE CAPACITY IN BREAST CANCER SURVIVORS (WF-97415)

Cardiovascular health assessment in routine cancer follow-up in community settings: survivor risk awareness and perspectives

DECREASED HDL IS ASSOCIATED WITH REDUCED LVEF DURING BREAST CANCER TREATMENT

Kathryn E Weaver Information

University

Position

Wake Forest School of Medicine

Citations(all)

5944

Citations(since 2020)

3269

Cited By

4060

hIndex(all)

40

hIndex(since 2020)

31

i10Index(all)

68

i10Index(since 2020)

61

Email

University Profile Page

Wake Forest University

Google Scholar

View Google Scholar Profile

Kathryn E Weaver Skills & Research Interests

Cancer Survivorship

Cancer Care Delivery

Top articles of Kathryn E Weaver

Title

Journal

Author(s)

Publication Date

Biomarkers associated with atherosclerosis-related cardiovascular dysfunction in cancer survivors treated with anthracyclines

Cancer Research

Kerryn W Reding

Alexi Vasbinder

Nathaniel O'Connell

Biniyam Demissei

Warren Szewczyk

...

2024/3/22

Abstract PO1-12-11: How do chemotherapy and age affect physical performance in breast cancer patients over 12 months of treatment? Results from the UPBEAT Study (UPBEAT WF-97415)

Cancer Research

Shirley Bluethmann

Beverly Levine

Brianna Leitzelar

Katherine Ansley

Alexandra Thomas

...

2024/5/2

Availability of cancer survivorship support services across the National Cancer Institute Community Oncology Research Program network

JNCI Cancer Spectrum

Jamie M Faro

Emily V Dressler

Carol Kittel

Dori M Beeler

Shirley M Bluethmann

...

2024/2/1

CHANGES IN SKELETAL MUSCLE QUALITY DURING RECEIPT OF ANTHRACYCLINE-BASED CHEMOTHERAPY

Journal of the American College of Cardiology

Jacob Rodrigues

Nathaniel OConnell

Kathryn Ruddy

Kathryn E Weaver

Glenn J Lesser

...

2024/4/2

Processes for identifying caregivers and screening for caregiver and patient distress in community oncology: results from WF-1803CD

JNCI: Journal of the National Cancer Institute

Chandylen L Nightingale

Anna C Snavely

Laurie E McLouth

Emily V Dressler

Erin E Kent

...

2024/2/1

ASSOCIATION OF INTERMUSCULAR FAT AND PHYSICAL ACTIVITY LEVELS ON EXERCISE CAPACITY IN BREAST CANCER SURVIVORS (WF-97415)

Journal of the American College of Cardiology

Lauren Daniel

Moriah P Bellissimo

Ralph Dagostino JR

Kristine Olson

Amy Ladd

...

2024/4/2

Cardiovascular health assessment in routine cancer follow-up in community settings: survivor risk awareness and perspectives

BMC cancer

Kathryn E Weaver

Emily V Dressler

Sydney Smith

Chandylen L Nightingale

Heidi D Klepin

...

2024/1/31

DECREASED HDL IS ASSOCIATED WITH REDUCED LVEF DURING BREAST CANCER TREATMENT

Journal of the American College of Cardiology

Eva Trakhtman

Leila Mabudian

Ralph Dagostino JR

Nathaniel OConnell

Kristine Olson

...

2024/4/2

A Pilot Study of Carotid Ultrasound to Identify Head and Neck Cancer Survivors with High Cardiovascular Risk after Radiation Therapy

International Journal of Radiation Oncology, Biology, Physics

RT Hughes

CH Tegeler

CL Nightingale

AC Snavely

CM Furdui

...

2024/4/1

BREAST CANCER THERAPY ASSOCIATED CHANGES IN THORACIC AORTIC DISTENSIBILITY IN THOSE WITH OR WITHOUT HYPERTENSION (UPBEAT WF-97415)

Journal of the American College of Cardiology

Alexis Fletcher

Amy Ladd

Kristine Olson

Riya Garg

Daniel Miller

...

2023/3/7

Pilot study of implementing the Shared Healthcare Actions & Reflections Electronic systems in Survivorship (SHARE‐S) program in coordination with clinical care

Cancer Medicine

Stephanie J Sohl

Rajani S Sadasivam

Carol Kittel

Emily V Dressler

Stacy Wentworth

...

2023/6

Sociodemographic and clinical factors associated with radiation treatment nonadherence and survival among rural and nonrural patients with cancer

Alcoholism: Clinical and Experimental Research

Veronica L Richards

Yiyang Liu

Jessica Orr

Robert F Leeman

Nancy P Barnett

...

2021/9

Availability of palliative specialty care for adults in community oncology: Results from the 2022 NCORP landscape assessment.

Tiffany M Statler

Emily Van Meter Dressler

Carol A Kittel

Melyssa Foust

Kah Poh Loh

...

2023/6/1

The association between an electronic health record (EHR)–embedded frailty index and patient-reported outcomes among patients with metastatic non–small-cell lung cancer on …

Saadia Nur

Laurie McLouth

Beverly J Levine

Thomas William Lycan

Jimmy Ruiz

...

2023/11

Physical activity during breast cancer therapy associates with preserved exercise capacity and cardiac function (WF97415)

JACC: CardioOncology

Moriah P Bellissimo

Justin M Canada

Jennifer H Jordan

Amy C Ladd

Kerryn W Reding

...

2023/3/21

serum measures of cholesterol, LDL, IL-6, TNF-a, nor CRP.

Alexander R Lucas

Ralph D’Agostino Jr

Jennifer H Jordan

Kerryn W Reding

Nathaniel S O’Connell

...

2023

Prognostic awareness, palliative care use, and barriers to palliative care in patients undergoing immunotherapy or chemo-immunotherapy for metastatic lung cancer

Journal of Palliative Medicine

Laurie E McLouth

Jennifer Gabbard

Beverly J Levine

Shannon L Golden

Thomas W Lycan

...

2023/6/1

Phase 3 randomized placebo-controlled trial of donepezil for late cancer-related cognitive impairment in breast cancer survivors exposed to chemotherapy from the Wake Forest …

Steve R Rapp

Emily Van Meter Dressler

W Mark Brown

James Lloyd Wade

Nguyet Le-Lindqwister

...

2023/6/1

Reducing Anxiety and Dyspnea via Device-Guided Breathing (RELAX): A Multi-Site Feasibility Study in Post-Treatment Lung Cancer Survivors at Community Cancer Clinics (WF-01213)

Integrative Cancer Therapies

Suzanne C Danhauer

Emily V Dressler

W Mark Brown

Chandylen L Nightingale

Gretchen A Brenes

...

2023/4

Recruitment of informal caregivers into research studies in community oncology practices: Results from the 2022 NCI Community Oncology Research Program (NCORP) Landscape …

Ying Wang

Chandylen L Nightingale

Christa M Braun-Inglis

Katherine R Sterba

Kathryn E Weaver

...

2023/11

See List of Professors in Kathryn E Weaver University(Wake Forest University)

Co-Authors

H-index: 49
Erin Kent

Erin Kent

University of North Carolina at Chapel Hill

H-index: 34
John Spangler

John Spangler

Wake Forest University

H-index: 33
Randi Foraker

Randi Foraker

Washington University in St. Louis

H-index: 27
David P. Miller, MD, MS

David P. Miller, MD, MS

Wake Forest University

academic-engine